AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Canctroz 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Lamiaceae Healthcare

Salt Composition

Letrozole (2.5mg)

Overview Canctroz 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Canctroz 2.5mg Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced cases, it aids in preventing cancer metastasis. Canctroz 2.5mg Tablets can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to individual needs and determined by your doctor to manage your symptoms effectively. Consistent use, as directed, is crucial. Common side effects include increased perspiration, weariness, hot flushes, and elevated cholesterol. Report any concerning symptoms to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or history of osteoporosis. Complete disclosure of all other medications is vital, as interactions may impact Canctroz's efficacy. Pregnancy or breastfeeding should also be reported. Your doctor may order blood tests to assess vitamin D levels and bone density before and throughout the treatment period.

Uses of Canctroz 2.5mg Tablet

Managing breast cancer

Major Benefits of Canctroz 2.5mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Canctroz 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Canctroz 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Canctroz 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Canctroz 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.

How Canctroz 2.5mg Tablet works:

Estrogen production is reduced by Canctroz 2.5mg Tablets, an aromatase inhibitor. This lowers estrogen levels, potentially halting or slowing the growth of estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingestion of alcohol alongside Canctroz 2.5mg Tablet presents no known adverse reactions.

PregnancyPregnancyUNSAFE

Using Canctroz 2.5mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in both animal and human studies indicates considerable harm to the unborn child.

Breast feedingBreast feedingUNSAFE

Lactation and Canctroz 2.5mg Tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Taking a Canctroz 2.5mg Tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Canctroz 2.5mg tablets are considered safe for individuals with kidney impairment; dose modification is unnecessary. Nevertheless, data regarding its use in patients with end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Canctroz 2.5mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Canctroz 2.5mg Tablet :

Should you forget a Canctroz 2.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Canctroz 2.5mg Tablet

LabelValue
Chemical Classification Diphenylmethane-based Compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Canctroz 2.5mg Tablet

Canctroz 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Canctroz 2.5mg tablets are anti-estrogens. They work by inhibiting the aromatase enzyme, thus lowering estrogen production. Since estrogen fuels the growth of certain breast cancers—called estrogen-dependent cancers—reducing estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue taking Canctroz 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Canctroz 2.5mg Tablet for five years, or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Canctroz 2.5mg Tablet followed by three years of tamoxifen may be used.
It's safe to take irbesartan and Canctroz 2.5mg Tablet concurrently, but monitor your blood pressure closely as Canctroz 2.5mg Tablet might elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Canctroz 2.5mg Tablets may cause cataracts. Seek immediate medical attention if you experience blurred vision or eye irritation.
Experiencing hot flushes may indicate a common side effect of Canctroz 2.5mg Tablet, linked to reduced estrogen. These usually lessen as your body adapts, though some may persist throughout treatment, subsiding afterward. Consult your doctor if hot flushes are excessively disruptive.
Canctroz 2.5mg Tablet may cause serious side effects, though these are rare. Such effects include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Canctroz 2.5mg Tablets can lead to bone thinning (osteoporosis) from reduced estrogen. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Canctroz 2.5mg Tablets to ovulation induction for treating anovulatory infertility.
Canctroz 2.5mg Tablet
232